MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00533208

Enrollment

766

Registered

2007-09-21

Start date

2003-07-31

Completion date

2003-10-31

Last updated

2015-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seasonal Allergies

Brief summary

To assess the efficacy of MK0524 on seasonal allergies.

Interventions

DRUGMK0524

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Person has had at least 2 years of seasonal allergies * Person has had a positive skin test to at least 1 of the allergens of the season * Person is a non-smoker

Exclusion criteria

* Person has been hospitalized within the last 4 weeks * Person is a female who has had a baby within the last 8 weeks or is still breast-feeding

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026